3-substituted quinuclidines and their use as nicotinic agonists

Details 3-substituted quinuclidines and their use as nicotinic agonists 3-substituted quinuclidines and their use as nicotinic agonists

2005-04-26

2005-04-26

Huang, Evelyn Mei (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S133000, C546S135000, C546S114000, C514S301000, C514S302000

Reexamination Certificate

active

06884807

ABSTRACT:
This invention relates to novel 3-substituted quinuclidine derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters.Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

REFERENCES:
patent: 4959367 (1990-09-01), King
patent: 5177084 (1993-01-01), Baker et al.
patent: 5227386 (1993-07-01), Böttcher et al.
patent: 5491148 (1996-02-01), Berger et al.
Sterling et al. Journal of Pharmaceutical Science. 1991, 80(8): 785-789.*
Holladay et al. J. Med. Chem. 1997, 40(26):4169-4188.*
Levin et al. Psychopharmacology. 1998, 138(3-4): 217-30.*
Johansson, Gary, et al. J. Med. Chem., vol. 40, pp. 3804-3819, 1997.
Database STN International. File Caplus, Caplus; accession No. 1974:82740, document No. 80:82740, Mikhlina, E. E., et al. vol. 7, No. 12, pp. 23-26, 1973.
Nilsson, B. M. et al. J. Med. Chem, vol. 38, pp. 473-487, 1995.
Nordvall, Gunnar, et al. J. Med. Chem, vol. 39, pp. 3269-3277, 1996.
Clark, R.D., et al. J. Med. Chem. vol. 36, pp. 2645-2657, 1993.

Affiliated with

Also associated with

Rating

3-substituted quinuclidines and their use as nicotinic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-substituted quinuclidines and their use as nicotinic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted quinuclidines and their use as nicotinic agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3370894